Drug Trial Radar · NCT06852768
Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Jan 10, 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Regenerative Ocular Immunobiologics LLCIndustry
- Sponsor type
- Industry
- First posted
- Feb 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of d-MAPPS™ Ophthalmic Solution in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGHVD)
Conditions
- oGHVD
Interventions
d-MAPPSBiological
Based on randomization d-MAPPS, will be self-administered, 2 drops into each eye four times a day (QID) a day for ninety (90) days.
PlaceboBiological
Based on randomization, Placebo, will be self-administered, 2 drops into each eye four times (QID) a day for ninety (90) days.
PI and Patient MaskedOther
Both the PI and the participant are masked on the drug administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes from Baseline utilizing University of North Carolina Dry Eye Management Scale (UNC DEMS) ScoresTime frame: Through study completion, an average of 4 months.
- Changes from Baseline utilizing Ocular Surface Disease Index (OSDI)Time frame: Through study completion, an average of 4 months.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Beverly Hills Institute of Ophthalmology
Beverly Hills, California
Beach Eye Medical Group
Huntington Beach, California
Regenerative Ocular Immunobiologics, LLC.
Palm Harbor, Florida
Glenn Eye Center
Lexington, Kentucky
Eyewell, LLC.
Boston, Massachusetts
BostonSight
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.